Kosterink JGW - Search Results

1

First-in-Human Phase I Clinical Trial of an SFV-Based RNA Replicon Cancer Vaccine against HPV-Induced Cancers.

Komdeur FL, Singh A, van de Wall S, Meulenberg JJM, Boerma A, Hoogeboom BN, Paijens ST, Oyarce C, de Bruyn M, Schuuring E, Regts J, Marra R, Werner N, Sluis J, van der Zee AGJ, Wilschut JC, Allersma DP, van Zanten CJ, Kosterink JGW, Jorritsma-Smit A, Yigit R, Nijman HW, Daemen T. Komdeur FL, et al. Among authors: kosterink jgw. Mol Ther. 2021 Feb 3;29(2):611-625. doi: 10.1016/j.ymthe.2020.11.002. Epub 2020 Nov 5. Mol Ther. 2021. PMID: 33160073 Free PMC article. Clinical Trial.

2

Development of a radioiodinated apoptosis-inducing ligand, rhTRAIL, and a radiolabelled agonist TRAIL receptor antibody for clinical imaging studies.

Duiker EW, Dijkers EC, Lambers Heerspink H, de Jong S, van der Zee AG, Jager PL, Kosterink JG, de Vries EG, Lub-de Hooge MN. Duiker EW, et al. Br J Pharmacol. 2012 Apr;165(7):2203-12. doi: 10.1111/j.1476-5381.2011.01718.x. Br J Pharmacol. 2012. PMID: 22014269 Free PMC article.

3

Measurement of tumor VEGF-A levels with 89Zr-bevacizumab PET as an early biomarker for the antiangiogenic effect of everolimus treatment in an ovarian cancer xenograft model.

van der Bilt AR, Terwisscha van Scheltinga AG, Timmer-Bosscha H, Schröder CP, Pot L, Kosterink JG, van der Zee AG, Lub-de Hooge MN, de Jong S, de Vries EG, Reyners AK. van der Bilt AR, et al. Clin Cancer Res. 2012 Nov 15;18(22):6306-14. doi: 10.1158/1078-0432.CCR-12-0406. Epub 2012 Sep 26. Clin Cancer Res. 2012. PMID: 23014526

4

Development, preclinical safety, formulation, and stability of clinical grade bevacizumab-800CW, a new near infrared fluorescent imaging agent for first in human use.

Ter Weele EJ, Terwisscha van Scheltinga AG, Linssen MD, Nagengast WB, Lindner I, Jorritsma-Smit A, de Vries EG, Kosterink JG, Lub-de Hooge MN. Ter Weele EJ, et al. Eur J Pharm Biopharm. 2016 Jul;104:226-34. doi: 10.1016/j.ejpb.2016.05.008. Epub 2016 May 12. Eur J Pharm Biopharm. 2016. PMID: 27179587

5

GMP manufacturing of Vvax001, a therapeutic anti-HPV vaccine based on recombinant viral particles.

Jorritsma-Smit A, van Zanten CJ, Schoemaker J, Meulenberg JJM, Touw DJ, Kosterink JGW, Nijman HW, Daemen T, Allersma DP. Jorritsma-Smit A, et al. Among authors: kosterink jgw. Eur J Pharm Sci. 2020 Feb 15;143:105096. doi: 10.1016/j.ejps.2019.105096. Epub 2019 Oct 25. Eur J Pharm Sci. 2020. PMID: 31669389 Free article.

6

Indium-111-labeled trastuzumab scintigraphy in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer.

Perik PJ, Lub-De Hooge MN, Gietema JA, van der Graaf WT, de Korte MA, Jonkman S, Kosterink JG, van Veldhuisen DJ, Sleijfer DT, Jager PL, de Vries EG. Perik PJ, et al. J Clin Oncol. 2006 May 20;24(15):2276-82. doi: 10.1200/JCO.2005.03.8448. J Clin Oncol. 2006. PMID: 16710024

7

Evaluation of co-trimoxazole in the treatment of multidrug-resistant tuberculosis.

Alsaad N, van Altena R, Pranger AD, van Soolingen D, de Lange WC, van der Werf TS, Kosterink JG, Alffenaar JW. Alsaad N, et al. Eur Respir J. 2013 Aug;42(2):504-12. doi: 10.1183/09031936.00114812. Epub 2012 Oct 25. Eur Respir J. 2013. PMID: 23100498 Free article.

8

Insufficient fluconazole exposure in pediatric cancer patients and the need for therapeutic drug monitoring in critically ill children.

van der Elst KC, Pereboom M, van den Heuvel ER, Kosterink JG, Schölvinck EH, Alffenaar JW. van der Elst KC, et al. Clin Infect Dis. 2014 Dec 1;59(11):1527-33. doi: 10.1093/cid/ciu657. Epub 2014 Aug 22. Clin Infect Dis. 2014. PMID: 25148892

9

Subtherapeutic Posaconazole Exposure and Treatment Outcome in Patients With Invasive Fungal Disease.

van der Elst KC, Brouwers CH, van den Heuvel ER, van Wanrooy MJ, Uges DR, van der Werf TS, Kosterink JG, Span LF, Alffenaar JW. van der Elst KC, et al. Ther Drug Monit. 2015 Dec;37(6):766-71. doi: 10.1097/FTD.0000000000000235. Ther Drug Monit. 2015. PMID: 26565789

10

Clarithromycin increases linezolid exposure in multidrug-resistant tuberculosis patients.

Bolhuis MS, van Altena R, van Soolingen D, de Lange WC, Uges DR, van der Werf TS, Kosterink JG, Alffenaar JW. Bolhuis MS, et al. Eur Respir J. 2013 Dec;42(6):1614-21. doi: 10.1183/09031936.00001913. Epub 2013 Mar 21. Eur Respir J. 2013. PMID: 23520311 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

154 results

Search Page